Prednisone dosing per body weight or body surface area in children with nephrotic syndrome—is it equivalent?-Reference-Cited by-同舟云学术

Prednisone dosing per body weight or body surface area in children with nephrotic syndrome—is it equivalent?

Published:2009-05 Issue:5 Volume:24 Page:1027-1031
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Feber Janusz,Al-Matrafi Jamila,Farhadi Elham,Vaillancourt Régis,Wolfish Norman

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-008-1089-2.pdf

Reference22 articles.

1. International Study of Kidney Disease in Children (1979) Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. J Pediatr 95:239–243

2. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1988) Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Lancet 1:380–383

3. Melvin T, Bennett W (1991) Management of nephrotic syndrome in childhood. Drugs 42:30–51

4. Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Eur J Pediatr 152:357–361

5. Gauthier B, Trachtman H (1999) Pharmacological treatment of nephrotic syndrome. Drugs Today (Barc) 35:13–26

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Hormone Dosing Estimations Based on Body Weight Versus Body Surface Area;Journal of Clinical Research in Pediatric Endocrinology;2023-08-23

2. Egyptian evidence -based pediatric clinical practice adapted guidelines for management of [1] steroid sensitive nephrotic syndrome (EPG/SSNS 2022);Egyptian Pediatric Association Gazette;2023-02-27

3. Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study;The Lancet Gastroenterology & Hepatology;2023-01

4. Steroid Sensitive Nephrotic Syndrome;Pediatric Kidney Disease;2023

5. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome;Pediatric Nephrology;2022-10-21